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In September 2017, the National Institute for Communicable Diseases 
(NICD) released a statement reporting an unprecedented increase in 
the number of Listeria cases across South Africa (SA). The increase 
was noted in the private and public sectors, with 190 confirmed 
cases of listeriosis across the country between January and August 
2017. The NICD also initiated enhanced surveillance at a number of 
hospitals nationally to gather additional information.[1] An increase 
in Listeria monocytogenes isolates was detected at our institution. 
Seven cases were reported at our laboratory in 2016. This figure 
increased to 14 confirmed listeriosis cases up to October 2017, with 
12 of these clustering between June and October (unpublished data –
Division of Medical Microbiology, Department of Pathology, Groote 
Schuur Hospital, Cape Town, SA, 2017). This case report increases 
awareness about L. monocytogenes and highlights the potential for 
co-infections. 
Case report
A 34-year-old man presented to a local hospital with a 3-week 
history of worsening cough and dyspnoea. He had a long-standing 
history of methamphetamine and cannabis use. The patient was 
also HIV-positive, with a recent absolute CD4+ count of 32 cells/µL. 
He was not on antiretroviral therapy and had not been admitted to 
hospital previously. He required intubation and ventilation because of 
respiratory distress, and the chest radiograph confirmed a multilobar 
pneumonia. The patient also required inotropes for septic shock and 
blood transfusion for severe anaemia (Hb 4.8 g/dL). Laboratory tests 
showed hypoglycaemia, hypocalcaemia and deranged liver enzymes, 
with normal kidney function. The patient was treated empirically 
with ceftriaxone and azithromycin before being transferred to a 
tertiary hospital intensive care unit. 
Management and investigations
A blood sample was taken on admission. After 14 hours, a Gram 
stain showed a combination of Gram-positive cocci in chains and 
small Gram-positive bacilli. The following day, based on preliminary 
laboratory results, the presence of Listeria and Streptococcus 
pneumoniae was suspected. Ampicillin was added to the patient’s 
antibiotic treatment, which had in the interim been escalated to 
imipenem by the attending clinicians owing to the severity of the 
illness and apparent concern about Gram-negative infection. The 
identification of both organisms was subsequently confirmed using 
routine laboratory methods (Fig. 1), including the Vitek 2 system 
(bioMérieux, SA). Both organisms were susceptible to penicillin, 
with mini mum inhibitory concentrations (MICs) of <0.06 µg/mL and 
0.125 µg/mL for S. pneumoniae and L. mono cytogenes, respectively. MIC 
determinations were done using the Vitek 2 streptococcal antibiotic 
susceptibility test card (AST-ST01, USA), supported by oxacillin 
disc testing for S. pneumoniae and Epsilometer testing (E-test) 
(bioMérieux, SA) for L. monocytogenes (Fig. 2). L. monocytogenes 
was also cultured from a second blood sample taken on admission, 
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Fig. 1. Mixed culture of Streptococcus pneumoniae and Listeria mono-
cytogenes on a 2% blood agar plate after 24 hours of incubation. There is 
alpha-haemolytic activity owing to S. pneumoniae (green arrow), and beta-
haemolytic activity produced by L. monocytogenes (blue arrow).
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which showed growth after 35 hours. Once antibiotic susceptibility 
results were available, definitive treatment with ampicillin and 
co-trimoxazole was initiated and administration of other antibiotics 
was discontinued. Acute renal failure at the time precluded the 
use of gentamicin. Meningo-encephalitis was not suspected, as 
no cells or organisms were present in the cerebrospinal fluid 
and there was no subsequent growth of bacteria. No pathology 
was noted on a computed tomography scan of the brain. No 
additional pathogens were detected and results of laboratory tests 
for Mycobacterium tuberculosis and Legionella serogroup 1 were 
negative. An echocardiogram revealed cardiomegaly with signs 
of biventricular failure, conduction abnormalities and an akinetic 
septum. An ischaemic hepatic liver injury was suspected. Multi-
organ failure followed an acute kidney injury secondary to sepsis, 
with a metabolic acidosis. A poor response to adequate treatment, 
decline in clinical presentation, two resuscitating events in the 
intensive care unit and poor prognosis with multi-organ failure 
prompted the withdrawal of active treatment. The patient passed 
away within 7 days of initial admission to hospital. 
Discussion
Dual infection with S. pneumoniae and L. monocytogenes is rare, but 
not unknown. A retrospective Danish study between 1997 and 2012 
reviewed 231 patients with L. monocytogenes bacteraemia and/or 
meningitis. The investigators documented 4 polymicrobial patients, 
2 of whom were co-infected with S. pneumoniae. One patient died 
after 2 days of definitive treatment with ampicillin in combination 
with gentamicin. The other patient received benzylpenicillin as 
monotherapy and survived. The remaining 2 co-infected patients 
were also infected with Escherichia coli.[2] L. monocytogenes has been 
documented as a rare concomitant infection in an immunocompetent 
patient with cryptococcal disease.[3] Interactions between bacteria and 
viruses are an emerging topic in human infections, with evidence 
that an indirect interaction between the measles virus and L. mono-
cytogenes promotes their co-infection.[4]
The mortality rate associated with L. monocytogenes is high – ranging 
from 20% to 30%, even with adequate antibiotic treatment. The 
variability in mortality can be explained by differences in risk factors, 
delay in diagnosis and inadequate empirical antibiotic treat ment.[2,5] 
Significant risk factors associated with 30-day mortality in the above-
mentioned Danish study included septic shock, altered mental 
state and inadequate treatment, especially with the cephalosporins.[2] 
The Multicentric Observational NAtional Study on LISteriosis and 
ListeriA (MONALISA)[6] was a national prospective observational 
cohort study performed in France between 2009 and 2013. It showed 
that the most important mortality prognostic factors for both 
Listeria bacteraemia and neurolisteriosis are multi-organ failure, 
aggravation of any pre-existing organ dysfunction, ongoing cancer, 
and monocytopenia.[6] It is unfortunate that our patient had multi-
organ failure, anaemia, septic shock and an altered mental state, 
despite being on adequate antibiotic treatment.
Therapeutic guidelines for the treatment of Listeria lack a strong 
evidence base, as no clinical trials have been done regarding this 
disease, which is considered rare. The incidence of listeriosis is 
estimated at 3 - 6 cases per million population per year in the western 
hemisphere.[6,7] Listeria is intrinsically resistant to cephalosporins, 
while ampicillin and benzylpenicillin remain the preferred antibiotics 
for treatment.[8,9] The addition of a second agent, usually gentamicin, 
is recommended in cases of meningitis/encephalitis, endocarditis 
or bacteraemia in immunocompromised hosts.[10,11] Co-trimoxazole 
is an acceptable alternative, either as monotherapy in patients with 
anaphylactic reactions to penicillins, or as combination therapy when 
gentamicin is not tolerated.[12-14] 
The diagnosis of Listeria organisms is made by culturing clinical 
specimens such as blood, cerebrospinal fluid, amniotic fluid, placenta 
or other sterile body fluids. Ideally, these specimens should be taken 
before administering antibiotics. In our case, ampicillin was added 
early, based on the provisional detection of Listeria co-infection. 
Blood cultures were done before starting antibiotics, and the broad-
spectrum antibiotics were subsequently de-escalated to narrow-
spectrum agents once the organisms had been identified. 
Conclusion
It can be concluded from this case that ampicillin may be added to the 
antibiotic cover if listeriosis is suspected in a high-risk group. Vulnerable 
patients include those who are immunocompromised, pregnant 
women, neonates and the elderly. However, in the setting of the current 
national listeriosis outbreak, ampicillin should be added to ceftriaxone/
cefotaxime for the empirical treatment of suspected bacterial meningitis 
in all patients.[15] Challenging empirical antibiotic choices might have 
to be made regarding co-infections, which require consultation with an 
infectious diseases specialist or microbiology pathologist. The current 
case report also highlights the importance of a close relationship between 
the local microbiologist and physician to select appropriate antibiotic 
therapy and potentially improve patient outcome.
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